Ahmed F Sherief
Overview
Explore the profile of Ahmed F Sherief including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghorab R, Fouad S, Sherief A, Taha R, Hamdy M, Darwish M, et al.
Innate Immun
. 2024 Dec;
:17534259241308661.
PMID: 39711476
Background: Globally, colorectal cancer (CRC) is among the most prevalent malignant tumors. It is characterized by unlimited proliferation, invasion, and metastasis. MicroRNA-126 (miR-126) has been shown in many studies to...
2.
Ghorab R, Fouad S, Sherief A, El-Sehsah E, Shamloul S, Taha S
Inflammation
. 2024 Aug;
PMID: 39103590
MicroRNA-146a (miR-146a) has been involved in the pathophysiology of inflammatory bowel disease (IBD). However, the precise processes are still not entirely understood. Contradictory studies suggest that miR-146a expression could be...
3.
Elbadry M, El-Raey F, Alboraie M, Abdel-Samiee M, Abdeltawab D, Ahmed M, et al.
BMC Gastroenterol
. 2024 Jun;
24(1):196.
PMID: 38872093
No abstract available.
4.
Elbadry M, El-Raey F, Alboraie M, Abdel-Samiee M, Abdeltawab D, Ahmed M, et al.
BMC Gastroenterol
. 2024 May;
24(1):186.
PMID: 38807055
Background: Egypt faces a significant public health burden due to chronic liver diseases (CLD) and peptic ulcer disease. CLD, primarily caused by Hepatitis C virus (HCV) infection, affects over 2.9%...
5.
Barakat E, Sherief A, Elsheikh N, Khalifa M
Egypt Liver J
. 2023 May;
13(1):27.
PMID: 37250271
Background: Reactivation of herpesviruses such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in COVID-19 patients reported in many studies in different countries during the pandemic. We aimed to measure prevalence...
6.
El-Kassas M, Elakel W, Alboraie M, Ezzat R, Abdelhakam S, Hassany M, et al.
Arab J Gastroenterol
. 2022 Apr;
23(2):120-124.
PMID: 35473688
Background And Study Aims: In resource-limited countries, non-invasive tests for assessing liver fibrosis are a potential alternative to costly endoscopic screening for esophageal varices. We aimed to validate several non-invasive...
7.
Dabbous H, Abd-Elsalam S, El-Sayed M, Sherief A, Ebeid F, Abd El Ghafar M, et al.
Arch Virol
. 2021 Nov;
167(1):277.
PMID: 34811571
No abstract available.
8.
Dabbous H, El-Sayed M, El Assal G, Elghazaly H, Ebeid F, Sherief A, et al.
Sci Rep
. 2021 Sep;
11(1):18983.
PMID: 34537808
No abstract available.
9.
Askar S, Sakr M, Alaty W, Sherief A, Rashad H, Eltabbakh M
JGH Open
. 2021 Jun;
5(6):664-668.
PMID: 34124383
Background And Aim: After a decrease of COVID-19 cases in summer, Europe faced the appearance of a COVID-19 second wave. IBD patients are more vulnerable to various emotional and psychological...
10.
Dabbous H, El-Sayed M, El Assal G, Elghazaly H, Ebeid F, Sherief A, et al.
Sci Rep
. 2021 Apr;
11(1):7282.
PMID: 33790308
Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of COVID-19 mild...